You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intratumoral

Showing 26 - 50 of 900
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Using Deep Learning and Radiomics to Diagnose Benign and

Completed
  • Breast Diseases
    • Jinan, Shandong, China
      QianfoshanH
    Sep 29, 2023

    Lung Cancer, Nonsmall Cell, Lung Cancer, Lung Cancer, Small Cell Trial in United States (NanoPac (sterile nanoparticulate

    Active, not recruiting
    • Lung Cancer, Nonsmall Cell
    • +3 more
    • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
    • Gainesville, Florida
    • +3 more
    Jan 9, 2023

    Recurrent Lung Cancer, Lung Cancer Trial (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))

    Not yet recruiting
    • Recurrent Lung Cancer
    • Lung Cancer
    • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • (no location specified)
    Nov 21, 2022

    Breast Cancer Female, Early-stage Breast Cancer Trial in Jette (Trimix, Placebo)

    Recruiting
    • Breast Cancer Female
    • Early-stage Breast Cancer
    • Jette, Brussel, Belgium
      UZ Brussel
    May 18, 2022

    Solid Tumor Trial in United States (drug, combination product, biological)

    Recruiting
    • Solid Tumor
    • Pembrolizumab
    • +2 more
    • Sacramento, California
    • +6 more
    Jan 3, 2023

    Advanced Melanoma Trial in New York, Houston (LTX-315 in combination with pembrolizumab)

    Recruiting
    • Advanced Melanoma
    • LTX-315 in combination with pembrolizumab
    • New York, New York
    • +7 more
    Jan 23, 2023

    Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

    Recruiting
    • Metastatic Solid Tumor
    • +3 more
    • 1.0% IP-001 for Injection
    • Bordeaux, France
    • +9 more
    Jan 26, 2023

    Hepatocellular Carcinoma Trial (SynOV1.1, Atezolizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • SynOV1.1
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Jan 31, 2023

    Melanoma Trial in United States (CAVATAK, Ipilimumab)

    Completed
    • Melanoma
    • Duarte, California
    • +10 more
    Jan 12, 2023

    Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

    Not yet recruiting
    • Diffuse Glioma
    • Malignant Glioma
    • Biospecimen Collection
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Feb 6, 2023

    Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

    Completed
    • Prostate Cancer
    • Intratumoral (IT) Poly ICLC 0.5 mg
    • +3 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Sep 8, 2022

    Skin Cancer, Mucosal Tumor of Oral Cavity, Soft Tissue Tumor Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters

    Recruiting
    • Skin Cancer
    • +2 more
    • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • Jerusalem, Israel
      Sharett institute, Hadassah University Hospital - Ein-Kerem
    Feb 16, 2022

    Solid Tumor Trial in Guangzhou (CAN1012)

    Recruiting
    • Solid Tumor
    • Guangzhou, Guangdong, China
      Canwell Biotech Limited
    Oct 13, 2022

    Solid Tumor, Cancer Metastatic Trial in Newton, Portland (CAN1012)

    Recruiting
    • Solid Tumor
    • Cancer Metastatic
    • Newton, Massachusetts
    • +1 more
    Feb 22, 2022

    Liver Metastases Trial (Diffusing Alpha Radiation Emitters Therapy (DaRT))

    Not yet recruiting
    • Liver Metastases
    • Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • (no location specified)
    Apr 23, 2023

    Pancreas Cancer Trial in Nijmegen (QuiremSpheres®)

    Recruiting
    • Pancreas Cancer
    • QuiremSpheres®
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Centre
    Jan 2, 2022

    Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

    Recruiting
    • Non Small Cell Lung Cancer
    • Solid Tumor
    • Jette, Brussels, Belgium
    • +1 more
    Sep 9, 2022

    Metastasis, Solid Tumor Trial (Peptide Alarm Therapy (PAT))

    Not yet recruiting
    • Metastasis
    • Solid Tumor
    • Peptide Alarm Therapy (PAT)
    • (no location specified)
    Nov 2, 2022

    Pancreas Cancer Trial in Nijmegen (Intratumoral)

    Recruiting
    • Pancreas Cancer
    • Intratumoral
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Centre
    May 19, 2023

    Solid Tumor, Advanced Cancer Trial in Wuxi (Oncolytic Virus Injection(RT-01))

    Recruiting
    • Solid Tumor
    • Advanced Cancer
    • Oncolytic Virus Injection(RT-01)
    • Wuxi, Jiangsu, China
      Wuxi People's Hospital
    Jan 19, 2022

    Soft Tissue Sarcoma Trial in New York (Tigilanol Tiglate)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • Tigilanol Tiglate
    • New York, New York
      Memorial Sloan Kettering Cancer Centre
    Mar 2, 2023

    Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell Trial in Tübingen, Warsaw, Saint Gallen (L19IL2 +L19TNF)

    Recruiting
    • Carcinoma, Basal Cell
    • Carcinoma, Cutaneous Squamous Cell
    • L19IL2 +L19TNF
    • Tübingen, Germany
    • +2 more
    Apr 19, 2022

    Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

    Not yet recruiting
    • Cutaneous Tumor
    • Malignant Solid Tumor
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Sep 9, 2022

    Advanced Cancer Trial in Villejuif (Ipilimumab, Nivolumab, Tilsotolimod)

    Active, not recruiting
    • Advanced Cancer
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Jul 21, 2021

    Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

    Completed
    • Solid Tumor
    • Lymphoma
    • MK-2118 (IT)
    • +2 more
    • La Jolla, California
    • +7 more
    Jan 23, 2023